TLDR:
- Vision care platform XP Health raised $33.2 million in Series B funding led by QED Investors.
- This funding will help XP Health expand its services and reach more customers in the vision care market.
In a recent funding round, vision care platform XP Health secured $33.2 million in Series B funding with QED Investors leading the charge. This new funding will allow XP Health to enhance its platform and expand its services in the vision care market. The company aims to reach a larger customer base and improve access to vision care services through its innovative platform.
XP Health is focused on revolutionizing the vision care industry by offering convenient and affordable services to its customers. With this new round of funding, the company is well-positioned to accelerate its growth and make a significant impact in the vision care market. The funding will also support XP Health in developing new technologies and enhancing its existing platform to better serve its customers.
QED Investors, a prominent investor in fintech and technology companies, saw great potential in XP Health’s vision care platform and decided to lead the Series B funding round. This vote of confidence from QED Investors is a reflection of XP Health’s innovative approach and strong business model. The partnership with QED Investors is expected to bring valuable insights and support to XP Health as it continues to grow and expand its presence in the vision care industry.
